<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">346155</id>
  <title nil="true"/>
  <common-name>6-imino-11-methyl-2-oxo-n-(2-phenylethyl)-7-(pyridin-3-ylmethyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide</common-name>
  <description>6-imino-11-methyl-2-oxo-n-(2-phenylethyl)-7-(pyridin-3-ylmethyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide is a chemical compound with the formula C27H24N6O2. It has an average molecular weight of 464.50 g/mol.</description>
  <cas>488796-47-0</cas>
  <pubchem-id>1077432</pubchem-id>
  <chemical-formula>C27H24N6O2</chemical-formula>
  <weight>464.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T09:30:38Z</created-at>
  <updated-at type="dateTime">2026-08-31T09:30:38Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CC4=CN=CC=C4)C(=O)NCCC5=CC=CC=C5</moldb-smiles>
  <moldb-formula>C27H24N6O2</moldb-formula>
  <moldb-inchi>InChI=1S/C27H24N6O2/c1-18-7-6-14-32-24(18)31-25-22(27(32)35)15-21(23(28)33(25)17-20-10-5-12-29-16-20)26(34)30-13-11-19-8-3-2-4-9-19/h2-10,12,14-16,28H,11,13,17H2,1H3,(H,30,34)</moldb-inchi>
  <moldb-inchikey>UCVXGHYIKYZMHK-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">464.196074</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342048</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>6-imino-11-methyl-2-oxo-n-(2-phenylethyl)-7-(pyridin-3-ylmethyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridopyrimidines</klass>
  <subklass>Pyrido[2,3-d]pyrimidines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296508</sync-id>
  <structure-inchikey>UCVXGHYIKYZMHK-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800000000000001000800100000000000000000000000004000000000000000000000000000020000100000000002004000000000004000000000002000080000000000400000010000080000140000420001000000000000000000000000000000000210000080000000000100000000000000100000000000000000100004000140040200000800400000000000080000000000100000000001000000000000000000400000000048000080108000000000000000000000000001000000100100000000020001000800000000000000000108000802000000220040000000000000000000001202040000000000400000000000040000101000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJwAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:58Z</structure-indexed-at>
</compound>
